beta-lactams has been researched along with cysteine in 13 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 40,132 | 418 | 11,457 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, EP; Huddleston, JA | 1 |
| Berwick, PG | 1 |
| Aharonowitz, Y; Mendelovitz, S | 1 |
| Dubus, A; Frère, JM; Jacobs, C; Monnaie, D; Normark, S | 1 |
| Eriguchi, Y; Haruta, S; Nukaga, M; O'Hara, K; Sawai, T; Yamaguchi, H; Yamamoto, ET | 1 |
| Critchley, IA; Janjic, N; Jones, RN; Pottumarthy, S; Whittington, WL | 1 |
| Arthur, M; Bougault, C; Hugonnet, JE; Lecoq, L; Pessey, O; Simorre, JP; Veckerlé, C | 1 |
| Brown, NG; Horton, LB; Lykissa, E; Mikulski, R; Palzkill, T; Phillips, KJ; Shanker, S; Venkataram Prasad, BV | 1 |
| Arthur, M; Bougault, C; Dubée, V; Hugonnet, JE; Lecoq, L; Simorre, JP; Triboulet, S | 1 |
| Brem, J; Chan, HTH; de Munnik, M; Kamps, JJAG; Kumar, K; Lohans, CT; Malla, TR; McArdle, DJB; Paton, RS; Schofield, CJ; Spencer, J; Tooke, CL; van Groesen, E | 1 |
| Bovenberg, RAL; Crismaru, CG; Driessen, AJM; Salo, O; Wu, M | 1 |
| Bovenberg, RAL; Driessen, AJM; Iacovelli, R; Mózsik, L | 1 |
| Aslam, H; Brewitz, L; Lukacik, P; Malla, TR; Mikolajek, H; Muntean, DG; Owen, CD; Salah, E; Schofield, CJ; Strain-Damerell, C; Tumber, A; Walsh, MA | 1 |
13 other study(ies) available for beta-lactams and cysteine
| Article | Year |
|---|---|
The stereochemistry of beta-lactam formation in cephalosporin biosynthesis.
Topics: Acremonium; beta-Lactams; Cephalosporins; Cysteine; Molecular Conformation; Stereoisomerism | 1978 |
Beta-lactam and aminoglycoside production from streptomycetes.
Topics: Anti-Bacterial Agents; beta-Lactams; Culture Media; Cysteine; Neomycin; Spores, Bacterial; Streptomyces; Streptomyces griseus; Streptomycin; Valine | 1988 |
beta-lactam antibiotic production by Streptomyces clavuligerus mutants impaired in regulation of aspartokinase.
Topics: Anti-Bacterial Agents; Aspartate Kinase; beta-Lactams; Cysteine; Drug Resistance, Microbial; Lysine; Mutation; Phosphotransferases; Streptomyces; Threonine | 1983 |
A dramatic change in the rate-limiting step of beta-lactam hydrolysis results from the substitution of the active-site serine residue by a cysteine in the class-C beta-lactamase of Enterobacter cloacae 908R.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Cysteine; Enterobacter cloacae; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Serine | 1993 |
Functional analysis of the active site of a metallo-beta-lactamase proliferating in Japan.
Topics: Anti-Bacterial Agents; Apoenzymes; Aspartic Acid; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Binding Sites; Binding, Competitive; Cysteine; Dose-Response Relationship, Drug; Escherichia coli; Histidine; Humans; Japan; Kinetics; Klebsiella pneumoniae; Ligands; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Zinc | 2000 |
Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
Topics: Anti-Bacterial Agents; beta-Lactams; Cysteine; Drug Antagonism; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Lactams; Microbial Sensitivity Tests; Neisseria gonorrhoeae; United States | 2005 |
Dynamics induced by β-lactam antibiotics in the active site of Bacillus subtilis L,D-transpeptidase.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; beta-Lactams; Catalytic Domain; Cysteine; Molecular Dynamics Simulation; Nitrobenzoates; Nuclear Magnetic Resonance, Biomolecular; Peptidyl Transferases; Substrate Specificity; Sulfhydryl Compounds | 2012 |
Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.
Topics: Amino Acid Substitution; beta-Lactamases; beta-Lactams; Catalytic Domain; Cysteine; Escherichia coli; Glycine; Kinetics; Ligands; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis; Protein Binding; Recombinant Proteins; Water; Zinc | 2012 |
Chemical shift perturbations induced by the acylation of Enterococcus faecium L,D-transpeptidase catalytic cysteine with ertapenem.
Topics: Acylation; Amino Acid Sequence; beta-Lactams; Catalytic Domain; Cysteine; Enterococcus faecium; Ertapenem; Molecular Sequence Data; Nuclear Magnetic Resonance, Biomolecular; Peptidyl Transferases | 2014 |
Non-Hydrolytic β-Lactam Antibiotic Fragmentation by l,d-Transpeptidases and Serine β-Lactamase Cysteine Variants.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cysteine; Molecular Conformation; Peptidyl Transferases | 2019 |
Impact of Classical Strain Improvement of
Topics: Amino Acids; beta-Lactams; Biosynthetic Pathways; Cysteine; Escherichia coli; Microorganisms, Genetically-Modified; Mutation; Penicillins; Penicillium chrysogenum | 2020 |
Identification of a conserved N-terminal domain in the first module of ACV synthetases.
Topics: 2-Aminoadipic Acid; Amino Acid Sequence; Amycolatopsis; Anti-Bacterial Agents; beta-Lactams; Biosynthetic Pathways; Cysteine; Genetic Variation; Penicillium; Peptide Synthases; Protein Domains | 2021 |
Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine.
Topics: Antiviral Agents; beta-Lactams; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Cysteine; Cysteine Endopeptidases; Humans; Penicillins; Protease Inhibitors; SARS-CoV-2 | 2022 |